Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue

Georgia R Sampedro1, Andrea C DeDent1, Russell E N Becker2

  • 1Department of Pediatrics Department of Microbiology.

Insights

Targeting Staphylococcus aureus alpha-toxin during primary skin infections can reduce recurrent disease severity. Neutralizing this toxin early offers a new therapeutic strategy for both initial and subsequent infections.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Staphylococcus aureus is a common cause of recurrent skin and soft-tissue infections (SSTIs).
  • Elevated antibodies against S. aureus alpha-toxin correlate with lower rates of recurrent SSTIs in children.
  • Alpha-toxin plays a role in the pathogenesis of S. aureus infections.

Purpose of the Study:

  • To investigate the role of alpha-toxin in recurrent SSTIs using a novel animal model.
  • To evaluate the therapeutic potential of antagonizing alpha-toxin during primary infection to prevent recurrent disease.

Main Methods:

  • Development and utilization of a novel mouse model for recurrent S. aureus SSTI.
  • Assessment of alpha-toxin expression during primary infection and its impact on recurrent disease severity.
  • Intervention strategies included a dominant-negative alpha-toxin mutant and a small molecule inhibitor of ADAM10 (alpha-toxin receptor).

Main Results:

  • Alpha-toxin expression during primary infection exacerbated the severity of recurrent SSTI.
  • Antagonizing alpha-toxin activity during primary infection significantly reduced the severity of reinfection abscesses.
  • Early neutralization of alpha-toxin demonstrated a protective effect against recurrent disease.

Conclusions:

  • Alpha-toxin is a critical factor in the pathogenesis of recurrent S. aureus SSTIs.
  • Targeting alpha-toxin, either through direct antagonism or inhibition of its receptor (ADAM10), represents a promising therapeutic approach.
  • Early intervention to neutralize alpha-toxin activity could mitigate both primary and recurrent S. aureus infections.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
148
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
954
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.0K